James D. Brenton

1997–2026 年に発表

148
論文数
35,918
被引用数
75
h 指数
136
i10 指数

被引用数

James D. Brenton の年別被引用数1961 年: 被引用 1 件1964 年: 被引用 1 件1982 年: 被引用 1 件1990 年: 被引用 1 件1997 年: 被引用 2 件1998 年: 被引用 15 件1999 年: 被引用 4 件2000 年: 被引用 12 件2001 年: 被引用 11 件2002 年: 被引用 8 件2003 年: 被引用 14 件2004 年: 被引用 8 件2005 年: 被引用 20 件2006 年: 被引用 57 件2007 年: 被引用 79 件2008 年: 被引用 112 件2009 年: 被引用 116 件2010 年: 被引用 165 件2011 年: 被引用 164 件2012 年: 被引用 178 件2013 年: 被引用 294 件2014 年: 被引用 361 件2015 年: 被引用 448 件2016 年: 被引用 486 件2017 年: 被引用 520 件2018 年: 被引用 565 件2019 年: 被引用 1,623 件2020 年: 被引用 1,912 件2021 年: 被引用 1,706 件2022 年: 被引用 1,435 件2023 年: 被引用 1,112 件2024 年: 被引用 1,593 件2025 年: 被引用 819 件2026 年: 被引用 32 件1962〜1963 年は被引用が無いため表示していません1965〜1981 年は被引用が無いため表示していません1983〜1989 年は被引用が無いため表示していません1991〜1996 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,693 件、この内訳の 22.7%中国: 引用元論文 2,226 件、この内訳の 10.8%イギリス: 引用元論文 1,942 件、この内訳の 9.4%イタリア: 引用元論文 984 件、この内訳の 4.8%カナダ: 引用元論文 951 件、この内訳の 4.6%ドイツ: 引用元論文 897 件、この内訳の 4.4%オーストラリア: 引用元論文 762 件、この内訳の 3.7%フランス: 引用元論文 730 件、この内訳の 3.5%スペイン: 引用元論文 609 件、この内訳の 3%オランダ: 引用元論文 565 件、この内訳の 2.7%日本: 引用元論文 518 件、この内訳の 2.5%スウェーデン: 引用元論文 369 件、この内訳の 1.8%
0%22.7%その他 26.1%

分野

  • Biochemistry, Genetics and Molecular Biology52.8%
  • Medicine38.4%
  • Immunology and Microbiology3.1%
  • Computer Science2.2%
  • Engineering0.9%
  • Neuroscience0.5%
  • その他2.1%

トピック

  • Cancer Genomics and Diagnostics9.1%
  • Ovarian cancer diagnosis and treatment4.4%
  • Cancer Cells and Metastasis3.2%
  • PARP inhibition in cancer therapy3%
  • Epigenetics and DNA Methylation2.6%
  • Cancer Immunotherapy and Biomarkers2.1%
  • その他75.6%

共著者

全論文

検索で開く
  1. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Carlos Caldas, Samuel Aparício - Nature 2012 被引用: 6,460

  2. Liquid biopsies come of age: towards implementation of circulating tumour DNA

    著者: , , , , , , , , - Nature reviews. Cancer 2017 被引用: 2,697

  3. Enhanced detection of circulating tumor DNA by fragment size analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kevin M. Brindle, Richard D. Baird, Morten Mau‐Sørensen, Christine Parkinson, Christopher G. Smith, James D. Brenton, Nitzan Rosenfeld - Science Translational Medicine 2018 被引用: 1,087

  4. Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Steven A. Narod, Brad H. Nelson, Kenneth P. Nephew, Paul D.P. Pharoah, Daniel J. Powell, Pilar Ramos, Iris L. Romero, Clare L. Scott, Anil K. Sood, Euan A. Stronach, Frances R. Balkwill - Nature reviews. Cancer 2015 被引用: 1,425

  5. A pan-cancer compendium of chromosomal instability

    著者: , , , , , , , , , , , , , - Nature 2022 被引用: 311

  6. Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Iain A. McNeish - The Lancet Oncology 2016 被引用: 1,200

  7. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

    著者: , , , , , , , , , , , , , , , , , - Nature 2013 被引用: 1,613

  8. Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA

    著者: , , , , , , , , , , , , , , - Science Translational Medicine 2012 被引用: 1,314

  9. BRCA Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2018 被引用: 432

  10. CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Grant W. Brown, Sohrab P. Shah, David W. Cescon, Tak W. Mak, Carlos Caldas, Peter C. Stirling, Phil Hieter, Shankar Balasubramanian, Samuel Aparício - Nature Communications 2017 被引用: 588

  11. Promises and challenges of adoptive T-cell therapies for solid tumours

    著者: , , , , , , , , , , , , , , , , , , , , - British Journal of Cancer 2021 被引用: 268

  12. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gerasimos Aravantinos, Norbert Arnold, Banu Arun, Brita Arver, Jacopo Azzollini, Judith Balmañà, Susana Banerjee, Laure Barjhoux, Rósa B. Barkardóttir, Yukie T. Bean, Matthias W Beckmann, Alicia Beeghly-Fadiel, Javier Benı́tez, Marina Bermisheva, Marcus Q. Bernardini, Michael J. Birrer, Line Bjorge, Amanda Black, Kenneth B. Blankstein, Marinus J. Blok, Clara Bodelón, Natalia Bogdanova, Anders Bojesen, Bernardo Bonanni, Åke Borg, Angela R. Bradbury, James D. Brenton, Carole Brewer, Louise A. Brinton, Per Broberg, Angela Brooks‐Wilson, Fiona Bruinsma, Joan Brunet, Bruno Buecher, Ralf Butzow, Saundra S. Buys, Trinidad Caldés, Maria A. Caligo, Ian Campbell, Rikki Cannioto, Michael E. Carney, Terence Cescon, Salina B Chan, Jenny Chang-Claude, Stephen J. Chanock, Xiao Qing Chen, Yoke-Eng Chiew, Jocelyne Chiquette, Wendy K. Chung, Kathleen Claes, Thomas Conner, Linda S. Cook, Jackie Cook, Daniel W. Cramer, Julie M. Cunningham, Aimee A. D’Aloisio, Mary B Daly, Francesca Damiola, Sakaeva Dina Damirovna, Agnieszka Dansonka‐Mieszkowska, Fanny Dao, Rosemarie Davidson, Anna DeFazio, Capucine Delnatte, Kimberly F. Doheny, Orland Dı́ez, Yuan Chun Ding, Jennifer A. Doherty, Susan M. Domchek, Cecilia M. Dorfling ほか 320 名 - Nature Genetics 2017 被引用: 553

  13. p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies

    著者: , , , , , , , - The Journal of Pathology 2019 被引用: 298

  14. Unravelling tumour heterogeneity using next-generation imaging: radiomics, radiogenomics, and habitat imaging

    著者: , , , , , , , - Clinical Radiology 2016 被引用: 358

  15. Unraveling tumor–immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexandra Snyder, Britta Weigelt, Evis Sala, Martin L. Miller - Nature Genetics 2020 被引用: 253

  16. Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Francesmary Modugno, Gregg Nelson, Jan Lubiński, Janusz Menkiszak, Jennifer Alsop, Jenny Lester, Jesús García-Donás, Jill Nation, Jillian A. Hung, José Palacios, Joseph H. Rothstein, Joseph L. Kelley, Jurandyr Moreira de Andrade, Luis A. Díaz‐Robles, Maria P. Intermaggio, Martin Widschwendter, Matthias W. Beckmann, Matthias Ruebner, Mercedes Jimenez‐Liñan, Naveena Singh, Oleg Oszurek, Paul R. Harnett, Peter Rambau, Hans‐Peter Sinn, Philipp Wagner, Prafull Ghatage, Raghwa Sharma, Robert P. Edwards, Roberta B. Ness, Sandra Oršulić, Sara Y. Brucker, Sharon E. Johnatty, Teri A. Longacre, Ursula Eilber, Valerie McGuire, Weiva Sieh, Yanina Natanzon, Zheng Li, Alice S. Whittemore, Anna DeFazio, Annette Staebler, Beth Y. Karlan, C. Blake Gilks, David D.L. Bowtell, Estrid Høgdall, Francisco José Cândido dos Reis, Helen Steed, Ian Campbell, Jacek Gronwald, Javier Benı́tez, Jennifer M. Koziak, Jenny Chang‐Claude, Kirsten B. Moysich, Linda E. Kelemen, Linda S. Cook, Marc T. Goodman, María J. García, Peter A. Fasching, Stefan Kommoss, Suha Deen, Susanne K. Kjær, Usha Menon, James D. Brenton, Paul D.P. Pharoah, Georgia Chenevix‐Trench, David G. Huntsman, Stacey J. Winham, Martin Köbel, Susan J. Ramus - JAMA Oncology 2017 被引用: 404

  17. Deconstruction of a Metastatic Tumor Microenvironment Reveals a Common Matrix Response in Human Cancers

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2017 被引用: 354

  18. Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary

    著者: , , , , , , , , , , , - The Journal of Pathology 2010 被引用: 832

  19. Rethinking ovarian cancer: recommendations for improving outcomes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature reviews. Cancer 2011 被引用: 1,507

  20. Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma

    著者: , , , , , , , , - The Journal of Pathology Clinical Research 2016 被引用: 390

  21. TGFBI Production by Macrophages Contributes to an Immunosuppressive Microenvironment in Ovarian Cancer

    著者: , , , , , , , , , , , , , , , , - Cancer Research 2021 被引用: 176

  22. Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study

    著者: , , , , , , , , , , , , , , , , - PLoS Medicine 2016 被引用: 300

  23. European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Susana Banerjee, Massimo Barberis, M.P. Barretina Ginesta, J.F. Baurain, Margherita Bignami, Line Bjørge, Paweł Blecharz, Ilan Bruchim, ME Capilna, Nicoletta Cerana, Americo Cicchetti, Dearbhaile Catherine Collins, Nicole Concin, Maurizio D’Incalci, Brittany A. Davidson, Thibault De La Motte Rouge, Pierandrea De Iaco, Fuat Demirkıran, Hannelore Denys, Thilo Doerk, Anne Dørum, Annamaria Ferrero, Alejandro Perez Fidalgo, Maurizio Genuardi, Laurence Gladieff, Rosalind Glasspool, Christoph Grimm, Murat Gültekin, E. Hahnen, Annette Hasenburg, Alinta Hegmane, Viola Heinzelmann, Estrid Høgdall, Ramūnas Janavičius, Sonata Jarmalaitė, Roshni Kalachand, Radka Kaneva, Saadettin Kılıçkap, Roman Kocián, D. Kolencik, Rebecca Kristeleit, Anna Kryzhanivska, Alexandra Léary, Birthe Lemley, Marjolijn J. L. Ligtenberg, José Antonio López‐Guerrero, Christopher J. Lord, E. Åvall‐Lundqvist, Johanna Mäenpää, Sven Mahner, Frederik Marmé, Christian Marth, Iain A. McNeish, Sabine Merkelbach‐Bruse, Marian J.E. Mourits, Nicola Normanno, Ana Oaknin, Kristiina Ojamaa, C. Papdimitriou, F. Penault-Llorca, Anna Myriam Perrone, Sandro Pignata, Eli Pikarsky, Étienne Rouleau, María Jesús Rubio, Anna Sapino, Barbara Schmalfeldt, Jalid Sehouli, Roni Shapira, Karina Dahl Steffensen ほか 12 名 - Annals of Oncology 2021 被引用: 164

  24. The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , James D. Brenton, Thomas P. Conrads, G. Larry Maxwell, Susan J. Ramus, Celeste Leigh Pearce, Malcolm C. Pike, Brad H. Nelson, Ellen L. Goode, Anna DeFazio, David D.L. Bowtell - Nature Genetics 2022 被引用: 113